ArticleCNS neuroscience & therapeutics2025

One-Year Outcomes After Intravenous Recombinant Tissue Plasminogen Activator for Ischemic Stroke: A Real-World Study.

Rui Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.